Get started
Author

Sung-Bae Kim

Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
2024 · Komal L. Jhaveri, Patrick Neven, et al. · New England Journal of Medicine · 247
PDF
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
2025 · Sibylle Loibl, Yeon Hee Park, et al. · New England Journal of Medicine · 105
Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study
2019 · Seock-Ah Im, Hirofumi Mukai, et al. · Journal of Global Oncology · 82
Importance of FOXP3 in prognosis and its relationship with p16 in tonsillar squamous cell carcinoma.
2013 · Kwonoh Park, Kyung Ja Cho, et al. · PubMed · 21
Impact of18F-FES PET/CT on Clinical Decisions in the Management of Recurrent or Metastatic Breast Cancer
2024 · Jeongryul Ryu, Jaewon Hyung, et al. · Journal of Nuclear Medicine · 13
PDF
Can concurrent chemoradiotherapy replace surgery and postoperative radiation for locally advanced stage III/IV tonsillar squamous cell carcinoma?
2013 · Geumju Park, Sang-Wook Lee, et al. · PubMed · 13
Predictive and prognostic value of 18F-FES PET/CT for patients with recurrent or metastatic breast cancer treated with endocrine therapy plus cyclin-dependent kinase 4/6 inhibitors
2025 · Hyehyun Jeong, Jeongryul Ryu, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 7
A Real-World Efficacy and Safety of KEYNOTE-522 Regimen in Patients With Early Triple-Negative Breast Cancer
2026 · Shinyoung Lee, Hyehyun Jeong, et al. · Journal of Breast Cancer · 2
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)
2025 · Jieun Lee, Hee Kyung Ahn, et al. · BMC Cancer · 2
PDF
Analysis of Recurrence Sites in Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiation with Elective Nodal Irradiation: Insights for Radiation Field Optimization
2025 · Ye Jin Yoo, Jeong Yun Jang, et al. · Annals of Surgical Oncology · 2
Phase II Trial of Neoadjuvant Docetaxel/Cisplatin/5-Fluorouracil Combined with Pegteograstim for Unresectable, Locally Advanced Sinonasal Squamous Cell Carcinoma: KCSG HN18-07
2024 · Bhumsuk Keam, Ho Jung An, et al. · Cancer Research and Treatment · 2
PDF
Is chemoradiotherapy equivalent to surgery for cT1bN0M0 esophageal cancer? A multicenter retrospective study (Korean Radiation Oncology Group 21-10)
2025 · Ha Un Kim, Hyeong Ryul Kim, et al. · European Journal of Surgical Oncology · 1
Real-World Outcomes and Biomarker Analysis Based on Routine Clinical, Laboratory, and Pathologic Parameters in Metastatic or Unresectable Esophageal Cancer Treated with First-Line Anti-PD-1 Plus Fluoropyrimidine and Platinum
2025 · Jiyun Jeong, Seyoung Seo, et al. · Cancers · 1
Clinical Benefit of Adjuvant Capecitabine According To Residual Cancer Burden in Patients With Triple-Negative Breast Cancer With Residual Disease Following Neoadjuvant Chemotherapy
2025 · Shinyoung Lee, Hyehyun Jeong, et al. · Clinical Breast Cancer · 1
Predictive and Prognostic Value of p16 in Head and Neck Squamous Cell Carcinoma Patients Treated with Molecular Targeted Agents or Immune Checkpoint Inhibitors: Subgroup Analysis of the TRIUMPH Study
2026 · Hyerim Ha, Sang Hoon Chun, et al. · Cancer Investigation
Abstract P2-05-17: The predictive and prognostic value of 18F-FES PET/CT in patients with advanced breast cancer treated with endocrine therapy with cyclin-dependent kinase 4/6 inhibitor
2025 · Hyehyun Jeong, Jeongryul Ryu, et al. · Clinical Cancer Research
Correction: Prognostic Impact of Inflammation-Based Factors in Patients with Esophageal Squamous Cell Carcinoma Achieving Pathological Complete Response After Neoadjuvant Chemoradiotherapy Followed by Surgery
2024 · Ji Yong Kim, Jae Kwang Yun, et al. · Annals of Surgical Oncology
PDF
Works count: 17
Citation count: 499
H-index: 7
I10-index: 6
Year
Topic
Type